NVCR vs PARA · rev $357.6M vs rev $5.0M
Novocure Ltd (NVCR) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Novocure Ltd (NVCR) is a medical devices company listed on US.
PARA (PARA) common stock.
Latest reported NVCR revenue for 2026-06-30 was $357.6M. Net income was -$86.8M. NVCR currently screens at market cap $1.99B.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
NVCR currently screens at market cap $1.99B. PARA currently screens at market cap $0.
Not investment advice. Open the NVCR and PARA stock pages for the full models.
Not investment advice.